You are here: Industry Insights > CDMO

News List

Oncobiologics Enters First CDMO Contract contractpharma
June 19, 2018
Oncobiologics has entered into a Master Services Agreement (MSA) with Sonnet BioTherapeutics, a privately held development stage biopharmaceutical company, and has officially launched its BioSymphony Platform-based contract development and manufacturing
WuXi Biologics to build new CDMO plant biospectrumasia
May 18, 2018
WuXi Biologics is planning to build an integrated biologics development, clinical and commercial manufacturing centre in the city of Shijiazhuang, capital of Hebei province in northern China.
Ardena acquisition strengthens API offering cphi-online
May 10, 2018
CDMO Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients
Sterling Pharma Invests £6M To Expand Offerings contractpharma
April 23, 2018
For its pilot plant facility to enhance scale-up and small to midscale commercial API manufacturing capabilities
CMAB Biopharma raises funds worth $34 M biospectrumasia
April 03, 2018
The funding proceeds will be used to upgrade CMAB’s 2,000L Good Manufacturing Practices (GMP) facilities.
Nanologica and Sterling partnership furthers new business venture cphi-online
March 19, 2018
Partnership enables production volumes of NLAB Saga chromatography material to increase from tens of kilograms to tens of tonnes.
Hovione divestment marks its commitment to supplying highly specialized APIs cphi-online
March 12, 2018
Portuguese company exits the large volume business of contrast media to concentrate on its CDMO business.
ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology contractpharma
February 08, 2018
Research License Agreement on Unique Technology to Assess Drug Effects on the Immune System in Vitro
Part i of CPhI Annual Report highlights unpredictability in CDMO growth over next five years pharmaasia
October 23, 2017
CPhI report shows growth in flow chemistry, overseas funds repatriation, API/product integration etc., but the rate of change remains unclear.
CPhI Worldwide 2017：Anticipated CDMO Market Trends in CPhI Report contractpharma
October 18, 2017
Niche services and technologies to dominate future acquisitions, increase in flow chemistry, fermentation anticipated

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page